Why It Matters

InductiveHealth Informatics is lobbying amid a fundamental crisis in U.S. public health surveillance capacity. The administration has proposed cutting CDC funding by 53 percent and eliminated over a dozen disease surveillance programs, even as measles cases surge to 2,242 reported cases across 49 outbreaks. The company’s push for federal investment in disease surveillance, immunization infrastructure, and chronic disease technology directly addresses this gap but faces headwinds from severe budget pressures.

However, Congress continues advancing bipartisan legislation on these priorities: the SEWER Act to expand wastewater surveillance, the Public Health Funding Restoration Act to restore $2 billion annually to public health programs, and the Newborn Screening Saves Lives Reauthorization Act to strengthen inherited disease data systems. With over $9 billion already invested in public health data modernization, InductiveHealth’s advocacy targets a real legislative opening.

By the Numbers

InductiveHealth Informatics began lobbying in March 2023 through Arnold & Porter Kaye Scholer LLP, spending $90,000 over six quarterly filings through April 2024.

In August 2025, InductiveHealth shifted to BGR Government Affairs LLC—a powerhouse firm representing major healthcare players like Pfizer Inc. and GSK plc. This Q4 2025 disclosure marks the third consecutive quarter with BGR, totaling $270,000 since August—triple their prior annual spend.

The three-person lobbying team combines formidable bipartisan Hill experience. Robert D. Walton served as Senior Counsel for Health for Sen. Bill Cassidy. Christopher P. Kelly worked as Legislative Assistant to Sen. Marsha Blackburn. Marvin Benito Figueroa served as Chief of Staff for Sen. Laphonza Butler and Senior Policy Adviser for Sen. Mark Warner.

The Agenda

InductiveHealth Informatics Inc. is lobbying Congress on three interconnected priorities: disease and syndromic surveillance systems, immunization infrastructure, and chronic disease technology. The company’s focus reflects ongoing congressional activity, including the SEWER Act for wastewater surveillance, the Suicide Prevention Act mandating syndromic surveillance, and the Public Health Funding Restoration Act.

Previous efforts focused on Pandemic All-Hazards Preparedness reauthorization and appropriations for public health data reporting within the fiscal 2024 HHS budget.

Broader Context

InductiveHealth’s lobbying comes as Congress grapples with tension over public health infrastructure. The administration has proposed slashing CDC funding while eliminating disease surveillance programs, creating pressure on disease detection capacity.

Yet bipartisan congressional interest in modernizing health data systems persists. The Suicide Prevention Act and BITE Act mandate real-time syndromic surveillance. Congress has held multiple HELP Committee hearings on CDC priorities and a Ways and Means hearing on chronic disease care coordination.

The urgency is underscored by the measles crisis, with House Appropriations Ranking Member Rosa DeLauro warning that CDC layoffs would compromise surveillance. Despite budget fights, the CDC’s Data Modernization Initiative has awarded $3.84 billion to improve state and local health data systems.

Between The Lines

Congressional momentum on InductiveHealth’s priorities continues despite budget pressures. Recent activity includes House Ways and Means hearings on chronic disease care coordination and Senate HELP Committee CDC oversight. The House passed Rep. Vern Buchanan’s Chronic Disease Flexible Coverage Act on a bipartisan basis.

The legislative momentum reflects frustration with surveillance gaps evident in the current measles outbreak. Yet InductiveHealth faces a counterwind: proposed 53% CDC funding cuts and eliminated disease-tracking programs create tension between congressional modernization interest and executive budget cuts.

Competitive Landscape

InductiveHealth isn’t alone in advocating for federal investment in disease surveillance. Washington State University reported Q3 2025 lobbying on "disease surveillance" and CDC budget funding. The National Association of Chronic Disease Directors lobbies on chronic disease prevention and data modernization infrastructure—representing potential coalition partners.

The Bottom Line

InductiveHealth Informatics Inc. is intensifying federal advocacy on disease surveillance amid severe budget pressures. The company’s $90,000 quarterly investment with BGR Government Affairs LLC brings 2025 spending with the firm to $270,000. InductiveHealth faces a paradox: significant federal modernization investments already underway, but acute uncertainty over future appropriations for agencies that would adopt its technology solutions.

Access the Legis1 platform for comprehensive political news, data, and insights.